Rock Springs Capital Management LP
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1595725
Baltimore, MD
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$221,240
+$101,288 QoQ
Shares Held
22,124
+75.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#196
of 318 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rock Springs Capital Management LP holds $59,831,908 across 7 Drug Manufacturers - Specialty & Generic names. BCRX ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
144,750 | $24,396,165 | |
| 2 | ALKS |
Alkermes plc.
|
199,811 | $10,470,096 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
245,500 | $10,072,865 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
499,764 | $8,975,761 | |
| 5 | TLPH |
Talphera, Inc.
|
3,589,186 | $3,696,861 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
59,000 | $1,998,920 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
22,124 | $221,240 |
All Filings in BCRX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $221,240 | 22,124 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $119,952 | 12,600 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,665,082 | 222,011 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,138,529 | 2,677,996 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,529,920 | 3,622,358 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,367,014 | 3,619,258 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,760,980 | 3,496,256 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,589,582 | 3,270,381 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,062,680 | 2,551,226 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,580,238 | 2,497,193 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,466,268 | 2,334,085 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,705,660 | 1,890,737 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,577,588 | 1,712,507 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,458,342 | 1,461,091 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||